Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Still, officials said, the overall risk to Oahu and Hawaii residents remains low as there is no evidence of sustained human-to-human transmission ... along with Influenza A, mpox, and Respiratory ...

It’s time for the provincial government to stop dragging its heels on paying for a pair of injections that can protect the ...

As infection rates of illnesses carried by mosquitoes increase, companies and researchers are racing to develop effective ...

In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of hospitalizations ...

A teenager in British Columbia was hospitalized in critical condition with the disease, and officials were working to find ...

In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

the Department of Public Health and Human Services (DPHHS) is encouraging Montanans to take precautions to help protect against COVID-19, influenza, pneumococcal pneumonia and respiratory syncytial ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...